Literature DB >> 34359345

A Systematic Review and Meta-Analysis of the Prognostic Impact of Pretreatment Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Parameters in Patients with Locally Advanced Cervical Cancer Treated with Concomitant Chemoradiotherapy.

Lu Han1, Qi Wang1,2, Lanbo Zhao1, Xue Feng1, Yiran Wang1, Yuliang Zou1, Qiling Li1.   

Abstract

BACKGROUNDS: The purpose of this paper is to investigate the prognostic value of fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) parameters in patients treated with concurrent chemoradiotherapy (CCRT) for locally advanced cervical cancer (LACC).
METHODS: Studies that met the following criteria were retrieved from PubMed and Embase: patients treated with CCRT for LACC; FDG PET/CT scans performed before CCRT treatment; and a detected relationship between the parameters of FDG PET/CT and the prognosis of patients. Pooled hazard ratios (HRs) with 95% confidence intervals (CIs) were used to estimate the overall survival (OS) or event-free survival (EFS).
RESULTS: In total, 14 eligible studies with 1313 patients were included in this meta-analysis. Patients with a high maximum standardized uptake value (SUVmax) have a shorter OS than those with a low SUVmax (HR = 2.582, 95% = CI 1.936-3.443, p < 0.001). Primary tumor SUVmax values (HR = 1.938, 95% CI = 1.203-3.054, p = 0.004) were significantly correlated with EFS, with a relatively high heterogeneity (I2 = 84% and I2 = 69.4%, respectively). Based on the limited data, the combined HR for EFS with the highest primary tumor total lesion glycolysis (TLG) and metabolic tumor volume (MTV) was 1.843 (95% CI = 1.100-3.086, p = 0.02) and 2.06 (95% CI = 1.21-3.51, p = 0.007), respectively. Besides, the combined HR for OS with the highest nodal SUVmax was 2.095 (95% CI = 2.027-2.166, p < 0.001).
CONCLUSION: A high primary SUVmax has a significant correlation with the OS and EFS of patients treated with CCRT for LACC and may therefore serve as a prognostic predictor. Due to the limited data, to explore the correlation between survival and TLG, MTV, and nodal SUVmax, further large-scale prospective studies are needed.

Entities:  

Keywords:  chemoradiotherapy; meta-analysis; positron-emission tomography; prognosis; uterine cervical neoplasms

Year:  2021        PMID: 34359345     DOI: 10.3390/diagnostics11071258

Source DB:  PubMed          Journal:  Diagnostics (Basel)        ISSN: 2075-4418


  3 in total

Review 1.  PET-CT in Clinical Adult Oncology-IV. Gynecologic and Genitourinary Malignancies.

Authors:  Ahmed Ebada Salem; Gabriel C Fine; Matthew F Covington; Bhasker R Koppula; Richard H Wiggins; John M Hoffman; Kathryn A Morton
Journal:  Cancers (Basel)       Date:  2022-06-18       Impact factor: 6.575

2.  The Diagnostic Performance of Maximum Uptake Value and Apparent Diffusion Coefficient in Differentiating Benign and Malignant Ovarian or Adnexal Masses: A Meta-Analysis.

Authors:  Xianwen Hu; Zhigang Liang; Chuanqin Zhang; Guanlian Wang; Jiong Cai; Pan Wang
Journal:  Front Oncol       Date:  2022-02-09       Impact factor: 6.244

3.  MRI-based radiomics value for predicting the survival of patients with locally advanced cervical squamous cell cancer treated with concurrent chemoradiotherapy.

Authors:  Xiaomiao Zhang; Jingwei Zhao; Qi Zhang; Sicong Wang; Jieying Zhang; Jusheng An; Lizhi Xie; Xiaoduo Yu; Xinming Zhao
Journal:  Cancer Imaging       Date:  2022-07-16       Impact factor: 5.605

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.